Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Clinical trial NCT06757647 · RECRUITING

Trial details

NCT number: NCT06757647
Sponsor: Seema Bhat
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start date: 2025-05-27
Primary completion: 2026-12-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.